141 related articles for article (PubMed ID: 9556974)
1. [Thiazolidindiones in type II diabetes mellitus].
Bornkessel B
Med Monatsschr Pharm; 1998 Mar; 21(3):66-8. PubMed ID: 9556974
[No Abstract] [Full Text] [Related]
2. [Tackling insulin resistance. Control of etiology in type 2 diabetes].
MMW Fortschr Med; 2000 May; 142(21):66-7. PubMed ID: 10872300
[No Abstract] [Full Text] [Related]
3. Troglitazone for non-insulin-dependent diabetes mellitus.
Med Lett Drugs Ther; 1997 May; 39(1001):49-51. PubMed ID: 9164446
[No Abstract] [Full Text] [Related]
4. Troglitazone: a new drug for type 2 diabetes mellitus.
Deb P; Bhatia E
Natl Med J India; 1998; 11(2):81-2. PubMed ID: 9624868
[No Abstract] [Full Text] [Related]
5. Troglitazone, an insulin action enhancer, improves glycaemic control and insulin sensitivity in elderly type 2 diabetic patients.
Kumar S; Prange A; Schulze J; Lettis S; Barnett AH
Diabet Med; 1998 Sep; 15(9):772-9. PubMed ID: 9737807
[TBL] [Abstract][Full Text] [Related]
6. Actos (pioglitazone HCL) provides a safe, effective alternative for patients formerly taking Rezulin.
Diabetes Technol Ther; 2000; 2(2):290-1. PubMed ID: 11469274
[No Abstract] [Full Text] [Related]
7. Diabetes drug Rezulin: take it, but take precautions.
Health News; 1999 May; 5(6):7. PubMed ID: 10546576
[No Abstract] [Full Text] [Related]
8. [Glitazones--a new therapeutic principle in diabetes].
Birkeland KI
Tidsskr Nor Laegeforen; 2001 Sep; 121(22):2617-9. PubMed ID: 11668762
[No Abstract] [Full Text] [Related]
9. [Prevention of arteriosclerosis with the insulin sensitizer pioglitazone. Early intervention in diabetic patients compensates "cell ignorance"].
MMW Fortschr Med; 2002 May; 144(21):52-3. PubMed ID: 12134427
[No Abstract] [Full Text] [Related]
10. [Against insulin resistance. Insulin sensitizers].
Verspohl EJ; Weiland F
Pharm Unserer Zeit; 2002; 31(3):280-92. PubMed ID: 12071125
[No Abstract] [Full Text] [Related]
11. Troglitazone.
Santiago JV
Compr Ther; 1997 Aug; 23(8):560-2. PubMed ID: 9283746
[No Abstract] [Full Text] [Related]
12. Warner-Lambert voluntarily withdraws Rezulin.
Diabetes Technol Ther; 2000; 2(2):290. PubMed ID: 11469273
[No Abstract] [Full Text] [Related]
13. Troglitazone in type II diabetes mellitus.
Sparano N; Seaton TL
Pharmacotherapy; 1998; 18(3):539-48. PubMed ID: 9620105
[TBL] [Abstract][Full Text] [Related]
14. NIH opens conflict-of-interest investigation.
Cimons M
Nat Med; 1999 Feb; 5(2):129-30. PubMed ID: 9930847
[No Abstract] [Full Text] [Related]
15. [Insulin sensitizer drugs--review].
Yamanouchi T
Nihon Rinsho; 2002 Sep; 60 Suppl 9():409-15. PubMed ID: 12387026
[No Abstract] [Full Text] [Related]
16. Diabetes recall. Though Rezulin's withdrawal is a blow for some patients, there are ways to cope. Here's how.
Gorman C
Time; 2000 Apr; 155(13):94. PubMed ID: 11009709
[No Abstract] [Full Text] [Related]
17. Avandia, a leading alternative for Rezulin patients, prescribed to more than 700,000 patients.
Diabetes Technol Ther; 2000; 2(2):292. PubMed ID: 11469275
[No Abstract] [Full Text] [Related]
18. Beneficial hepatic effect of troglitazone in a patient with antimitochondrial antibody-negative primary biliary cirrhosis.
Okai T; Mouri H; Yamaguchi Y; Nakanuma Y; Sawabu N
Am J Gastroenterol; 2002 Jan; 97(1):209-10. PubMed ID: 11808957
[No Abstract] [Full Text] [Related]
19. Combination therapy in type 2 diabetes: the role of repaglinide.
Moses R
J Assoc Physicians India; 2001 Jan; 49 Spec No():62-8. PubMed ID: 11235608
[No Abstract] [Full Text] [Related]
20. Severe but reversible hepatitis induced by troglitazone.
Schiano T; Dolehide K; Hart J; Baker AL
Dig Dis Sci; 2000 May; 45(5):1039-42. PubMed ID: 10795774
[No Abstract] [Full Text] [Related]
[Next] [New Search]